Results 91 to 100 of about 94,073 (238)
Cerebral salt wasting in a patient with myeloproliferative neoplasm
BMC Neurology, 2019 Background Cerebral salt wasting (CSW) is a rare metabolic disorder with severe hyponatremia and volume depletion usually caused by brain injury like trauma, cerebral lesion, tumor or a cerebral hematoma.
Lea Orlik +3 more
doaj +1 more source
British Journal of Haematology, EarlyView.Summary Haematological malignancies are rare in primary care and are hard to predict. Existing prediction models often require a specific working diagnosis and are based on extensive clinical information, access to which may be limited at initial work‐up in primary care.
Mathilde Egelund Christensen +9 more
wiley +1 more source
Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis
, 2017 We studied non-driver mutations in 62 subjects with myeloproliferative neoplasm (MPN)-associated myelofibrosis upon diagnosis, including 45 subjects with primary myelofibrosis (PMF) and 17 with post-polycythemia vera or post-essential thrombocythemia ...
Zhen Song +11 more
core +1 more source
Chronic myelomonocytic leukemia: A rare hematologic malignancy that needs due consideration
, 2020 Chronic Myelomonocytic Leukemia (CMML) is a malignant hematopoietic stem cell disorder with clinical and pathological features of both a myeloproliferative neoplasm and myelodysplastic syndrome [1]. According to the 2016 WHO classification of hematologic
Yosef Alebel, Temesgen Assefa
core +1 more source
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm. [PDF]
, 2016 Transduction-transplantation is a quick and efficient way to model human hematologic malignancies in mice. This technique results in expression of the gene of interest in hematopoietic cells and can be used to study the gene's role in normal and/or ...
Morse, Sarah J +2 more
core +1 more source
, 2022 Supplementary Data from Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative ...
Scott A. Oakes (15131694) +27 more
core +1 more source
HaematologicaIntroduction: Myeloproliferative neoplasms (MPNs) are a main cause of splanchnic vein thrombosis (SVT), with JAK2V617F as a known risk factor. The impact of co-occurring mutations on thrombosis risk remains unclear.
L. Fagiolo +12 more
doaj
British Journal of Haematology, EarlyView.Summary Complete remission (CR) rates for patients with acute myeloid leukaemia (AML) treated with intensive chemotherapy (IC) have increasingly improved. Yet, relapse remains a concern with a dismal prognosis. In this report, results are presented of a retrospective analysis comparing salvage therapy based on intermediate (I) or high (H)‐dose ...
Pierre‐Yves Dumas +22 more
wiley +1 more source
Survival of patients with chronic myeloproliferative neoplasms and new primary cancers:a population-based cohort study [PDF]
, 2015 Background: Patients with chronic myeloproliferative neoplasms are at increased risk of new solid or haematological cancers, but how prognosis is affected in patients with preceding myeloproliferative neoplasms is unclear.
Hasselbalch, Hans Carl +6 more
core +1 more source
, 2022 Supplemental material, sj-tiff-2-taj-10.1177_20406223221125691 for Characteristics of myeloproliferative neoplasm-associated portal hypertension and endoscopic management of variceal bleeding by Xiaoquan Huang, Ming Zhang, Yingjie Ai, Siyu Jiang, Mei ...
Yourong Jian (13849565) +9 more
core +1 more source